Moleculin Biotech

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$63
Gross Profit
-9
-21
-29
-31
EBITDA
13,888
-25,378
-7,611
-5,912
EBIT
13,879
-25,399
-7,640
-5,943
Net Income
15,552
-25,399
-7,640
-6,436
Net Change In Cash
0
0
0
63
Free Cash Flow
-5,366
-7,223
-5,582
-4,564
Cash
8,878
6,703
7,557
7,716
Basic Shares
11,845
1,492
621
3

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-90
-126
-127
-222
EBITDA
-25,013
-26,515
-29,504
-30,510
EBIT
-25,103
-26,641
-29,631
-30,640
Net Income
-33,560
-21,763
-29,769
-29,025
Net Change In Cash
0
0
0
0
Free Cash Flow
-22,735
-23,875
-24,225
-27,706
Cash
8,878
4,278
23,550
43,145
Basic Shares
11,845
137
79
76

Earnings Calls

QuarterEPS
2025-12-31
$4.82
2025-09-30
-$0.68
2025-06-30
-$0.49
2025-03-31
-$0.69